An AI model that learns without human input—by posing interesting queries for itself—might point the way to superintelligence. Save this story Save this story Even the smartest artificial intelligence ...
Imagine snapping a photo of your favorite object, a vintage car, a family heirloom, or even your pet, and instantly transforming it into a lifelike 3D model. Thanks to Meta’s SAM 3D, this futuristic ...
Gilead Sciences, Inc. GILD announced that the investigational single-tablet regimen of bictegravir and lenacapavir for the treatment of HIV met the primary endpoint in the late-stage ARTISTRY-2 study.
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment responses ...
– Positive Phase 3 Results from Both ARTISTRY-2 and ARTISTRY-1 Trials will Form the Basis of Regulatory Submissions – Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from ...
Are Machine Learning (ML) algorithms superior to traditional econometric models for GDP nowcasting in a time series setting? Based on our evaluation of all models from both classes ever used in ...
A paper co-authored by Prof. Alex Lew has been selected as one of four "Outstanding Papers" at this year's Conference on Language Modeling (COLM 2025), held in Montreal in October. Lew and his ...
Gilead Sciences, Inc. GILD announced that its investigational single-tablet regimen (STR) of bictegravir and lenacapavir for HIV-1 Treatment met the primary endpoint in the late-stage ARTISTRY-1 study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results